The regulatory subunit of PI3K, p85β, induces cellular transformation, enhanced cell proliferation and increased PI3K signaling

被引:3
|
作者
Ito, Yoshihiro [1 ]
Hart, Jonathan R. [1 ]
Ueno, Lynn [1 ]
Vogt, Peter K. [1 ]
机构
[1] Scripps Res Inst, La Jolla, CA 92037 USA
关键词
D O I
10.1158/1538-7445.AM2014-3339
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3339
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Requirement for p85α regulatory subunit of class IA PI3K in myeloproliferative disease driven by an activation loop mutant of KIT
    Munugalavadla, Veerendra
    Sims, Emily C.
    Chan, Rebecca J.
    Lenz, Stephen D.
    Kapur, Reuben
    [J]. EXPERIMENTAL HEMATOLOGY, 2008, 36 (03) : 301 - 308
  • [42] PI3K Signaling in Neutrophils
    Hawkins, Phillip T.
    Stephens, Len R.
    Suire, Sabine
    Wilson, Michael
    [J]. PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 1, 2010, 346 : 183 - 202
  • [43] p85 plays a critical role in controlling flux through the PI3K/PTEN signaling axis through dual regulation of both p110 (PI3K) and PTEN
    Anderson, Deborah H.
    [J]. CELL CYCLE, 2010, 9 (11) : 2055 - 2056
  • [44] Peptide prodrugs targeting the SH2 domains of p85 block PI3K signaling
    Mandal, Pijus K.
    Yao, Yanhua
    Bresnick, Anne R.
    Backer, Jonathan M.
    McMurray, John S.
    [J]. CANCER RESEARCH, 2016, 76
  • [45] Domain analysis reveals striking functional differences between the regulatory subunits of phosphatidylinositol 3-kinase (PI3K), p85α and p85β
    Ito, Yoshihiro
    Vogt, Peter K.
    Hart, Jonathan R.
    [J]. ONCOTARGET, 2017, 8 (34) : 55863 - 55876
  • [46] Receptor tyrosine phosphatase, CD148, binds to and dephosphorylates p85, a regulatory subunit of phosphatidylinositol-3′ kinase (PI3k).
    Tsuboi, N
    Utsunomiya, T
    Takahashi, K
    Crooke, C
    Noda, M
    Daniel, TO
    Takahashi, T
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 16A - 16A
  • [47] Class I PI3K in oncogenic cellular transformation
    L Zhao
    P K Vogt
    [J]. Oncogene, 2008, 27 : 5486 - 5496
  • [48] Targeting a PI3K subunit in schizophrenia
    Charlotte Harrison
    [J]. Nature Reviews Drug Discovery, 2012, 11 (8) : 602 - 602
  • [49] Efficacy of PI3K inhibitors to PI3K mutants in enzyme and cell levels
    Dan, Shingo
    Sugita, Hironobu
    Yamazaki, Kanami
    Yamori, Takao
    [J]. CANCER RESEARCH, 2009, 69
  • [50] Regulation of the PI3K pathway through a p85α monomer-homodimer equilibrium
    Cheung, Lydia W. T.
    Walkiewicz, Katarzyna W.
    Besong, Tabot
    Hawke, David
    Arold, Stefan T.
    Mills, Gordon B.
    [J]. CANCER RESEARCH, 2015, 75